Lasa Supergenerics Ltd

Tue 15/09/2026,15:54:40 | NSE : LASA

₹6.20-0.32 (-4.91%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 6.20

Previous Close

₹ 6.52

Volume

18314

Mkt Cap ( ₹ Cr)

₹ 31.06

High

₹ 6.20

Low

₹ 6.20

52 Week High

₹ 14.08

52 Week Low

₹ 5.67

Book Value Per Share

₹ 9.19

Dividend Yield

0.00

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Lasa Supergenerics Ltd

Your Vote -

Buy

26.92%

Hold

3.85%

Sell

69.23%

26.92%

26 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Lasa Supergenerics Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Lasa Supergenerics - General Updates

    9 Sep 2026, 5:40PM Lasa Supergenerics Limited has informed the Exchange about General Updates

  • Lasa Supergenerics - Outcome of Board Meeting

    9 Sep 2026, 5:25PM Lasa Supergenerics Limited has informed the Exchange regarding Outcome of Board Meeting held on September 09, 2026.

  • Lasa Supergenerics - Notice Of The Annual General Meeting

    9 Sep 2026, 5:28PM Notice of annual general meeting

  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of The Baord Meeting

    9 Sep 2026, 5:09PM Outcome of the board meeting

  • Lasa Supergenerics - Clarification - Financial Results

    2 Sep 2026, 3:02PM The Exchange has sought clarification from Lasa Supergenerics Limited for the quarter ended 30-Jun-2026 with respect to Regulation 33 of the SEBI (Lis

  • Lasa Supergenerics - Outcome of Board Meeting

    26 Aug 2026, 1:22PM Appointment of Mr Janardan Savala as additonal director in capacity of Executive Director

  • Lasa Supergenerics - Board Meeting Outcome for Appointment Of Mr Janardan Savala As On 26-08-2026 Additional Director In The

    26 Aug 2026, 1:11PM Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today i.e . August 26, 2026 which was commenced at 11

  • Lasa Supergenerics - Cessation

    25 Aug 2026, 4:29PM Lasa Supergenerics Limited has informed the Exchange regarding Cessation of Mr. ganesh as Executive Director of the company w.e.f. August 25, 2026.

  • Lasa Supergenerics - Resignation of Director/KMP/SMP

    25 Aug 2026, 4:21PM Lasa Supergenerics Limited has informed the Exchange about Resignation of Director/KMP/SMP

  • Lasa Supergenerics - Announcement under Regulation 30 (LODR)-Cessation

    25 Aug 2026, 4:15PM Resignation of Mr. Ganesh Potdar executive director as on 25-08-2026

  • Lasa Supergenerics - Integrated Filing- Financial

    14 Aug 2026, 7:00PM Integrated filing for Quarter ended 30 june, 2026

  • Lasa Supergenerics - Integrated Filing For Quarter Ended June 30, 2026

    14 Aug 2026, 6:57PM Integrated filing for Quarter ended June 30, 2026

  • Lasa Supergenerics - Outcome of Board Meeting

    14 Aug 2026, 6:33PM Lasa Supergenerics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

  • Lasa Supergenerics - Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended June 30, 2026

    14 Aug 2026, 6:24PM Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Boar

  • Lasa Supergenerics - Board Meeting Intimation for The Quarter Ended June 30,2026

    4 Aug 2026, 12:32PM Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider a

  • Lasa Supergenerics - Structural Digital Database

    18 Jul 2026, 12:02PM SDD certificate for the quarter ended June 2026

  • Lasa Supergenerics - Trading Window

    29 Jun 2026, 4:02PM Lasa Supergenerics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation

  • Lasa Supergenerics to start trial runs from Nov 25

    23 Nov 2017 , 12:13PM Lasa Supergenerics announces that it will start its pilot production trial runs at its Unit IV from November 25, 2017
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Lasa Supergenerics Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 59.3702 83.7132 96.6762 118.2859 148.6341
Liabilities 59.3702 83.7132 96.6762 118.2859 148.6341
Equity 50.1013 50.1012 50.1012 50.1012 40.6727
Gross Profit -7.3666 6.2659 2.1658 -6.5935 15.6327
Net Profit -34.0903 -14.7573 -21.7306 -38.6207 -5.3672
Cash From Operating Activities -0.0737 -2.8237 2.1387 -17.3004 10.4898
NPM(%) -135.59 -10.35 -20.82 -29.8 -3.91
Revenue 25.1407 142.4481 104.335 129.5678 137.1267
Expenses 32.5073 136.1822 102.1692 136.1613 121.494
ROE(%) -74.03 -32.05 -47.19 -83.87 -11.65

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
16 Sep 2022 0.25 2.5 0 62.35
15 Sep 2021 0.25 2.5 0 73.6

Peers

Other companies within the same industry or sector that are comparable to Lasa Supergenerics Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1756.90 3.77 15.45 5.69 1071.07 0.40
Sharda Cropchem Ltd 745.50 -1.05 10.74 56.57 754.66 2.01
Amines and Plasticizers Ltd 160.40 -3.09 22.88 34.50 331.99 0.31
Indogulf Cropsciences Ltd 65.27 -0.49 10.70 30.59 63.31 0.00

Company Info

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Lasa Supergenerics Limited was incorporated as a public limited company on March 11, 2016 (Company Registration Number: 274202 and having Corporate Identification Number: U24233MH2016PLC274202) under the Companies Act, 2013 with the Registrar of Companies, Maharashtra ("RoC") 2021 -LASA launched new product Oxyclozanide Creating new Capacity as a brown field expansion issued by the company.

Parent Organisation

Lasa Supergenerics Ltd.

Founded

11/11/2016

Managing Director

Dr.Omkar Pravin Herlekar

NSE Symbol

LASABE

FAQ